Elanco Animal Health (ELAN) Tops Q2 EPS by 2c, Offers FY Guidance

Elanco Animal Health (NYSE: ELAN) reported Q2 EPS of $0.28, $0.02 better than the analyst estimate of $0.26. Revenue for the quarter came in at $1.28 billion versus the consensus estimate of $1.23 billion.

GUIDANCE:

Elanco Animal Health sees Q3 2021 EPS of $0.15-$0.19, versus the consensus of $0.20. Elanco Animal Health sees Q3 2021 revenue of $1.075-1.1 billion, versus the consensus of $1.09 billion.

Elanco Animal Health sees FY2021 EPS of $0.97-$1.03, versus the consensus of $1.04. Elanco Animal Health sees FY2021 revenue of $4.68-4.73 billion, versus the consensus of $4.71 billion.

For earnings history and earnings-related data on Elanco Animal Health (ELAN) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Lennar Corp. (LEN) Misses Q2 EPS by 1c
• Limoneira (LMNR) Misses Q2 EPS by 8c, Beats on Revenue